Non-Hormonal Treatments

For a long time, women who couldn't or didn't want to take hormone therapy were essentially told to grin and bear it. The menopause transition, with all its disruptive symptoms, was treated as something to wait out. That era is finally ending. There are now real, evidence-based non-hormonal options for hot flashes, mood changes, sleep disruption, and genitourinary symptoms - including newer medications that didn't exist even a few years ago.

This article walks through the non-hormonal treatments that actually have evidence behind them, who they work for, and how to think about building a non-hormonal plan with your provider.

Who should consider non-hormonal options

Non-hormonal treatments are appropriate in several situations:

• History of hormone-sensitive cancer (especially breast or endometrial cancer)
• History of blood clots, stroke, or certain cardiovascular conditions that make systemic estrogen risky
• Personal preference against hormone therapy for any reason
• Mild symptoms that don't justify systemic hormone therapy
• Residual symptoms on HRT that need additional management

Importantly, choosing non-hormonal care does not mean giving up on feeling better. The right plan can meaningfully reduce hot flashes, improve sleep, address mood, and restore genitourinary comfort.

Veozah (fezolinetant): the first NK3 antagonist

Veozah was FDA-approved in 2023 and represented the first genuinely new non-hormonal treatment for vasomotor symptoms in decades. It works on the neurokinin 3 (NK3) receptor in the hypothalamus, which becomes hyperactive during menopause and drives hot flashes. Blocking that receptor reduces flash frequency and severity.

In clinical trials, fezolinetant reduced moderate-to-severe hot flashes by roughly 60% at 12 weeks. It works relatively quickly - many women notice improvement within a few weeks.

• Who it's for: women with moderate to severe hot flashes who can't or won't use HRT
• Dosing: one tablet daily
• Side effects: generally mild, though liver enzyme monitoring is required
• Cost: expensive without insurance; coverage is improving but variable

Elinzanetant: the dual-action newer option

Elinzanetant is a newer dual NK1/NK3 receptor antagonist that has shown promising results for both hot flashes and sleep disruption. FDA approval timelines for elinzanetant are still evolving, but it represents the next generation of non-hormonal vasomotor treatments. Ask your provider whether it's appropriate and available for you.

SSRIs and SNRIs

Low-dose antidepressants have been used off-label for hot flashes for years, and one, paroxetine (Brisdelle), is FDA-approved specifically for menopausal hot flashes at a low dose. Evidence supports:

• Paroxetine (Brisdelle, Paxil) - reduces hot flashes by roughly 30-60%; FDA-approved at 7.5 mg for this indication
• Venlafaxine (Effexor) - reduces hot flashes significantly; often used at 37.5-75 mg daily
• Escitalopram (Lexapro) and citalopram - evidence for modest to moderate hot flash reduction
• Desvenlafaxine - an SNRI with evidence in menopause

These medications also address mood symptoms, which often overlap with menopause. For women who have both hot flashes and depression or anxiety, a well-chosen SSRI or SNRI can address both in one prescription.

An important note: paroxetine and fluoxetine can interfere with tamoxifen metabolism. Breast cancer survivors on tamoxifen should discuss this carefully with their oncologist.

Gabapentin and pregabalin

Originally developed for seizures and nerve pain, gabapentin has been used off-label for hot flashes - particularly nighttime hot flashes - for over two decades. It reduces hot flash frequency and severity and, taken at bedtime, often improves sleep.

• Typical dose: 300-900 mg at bedtime, sometimes split through the day
• Best for: night sweats and hot flashes that disrupt sleep
• Side effects: drowsiness, dizziness, occasional weight gain

Pregabalin (Lyrica) is a related medication sometimes used similarly.

Oxybutynin and clonidine

Two other older medications have evidence for hot flashes:

• Oxybutynin - an anticholinergic medication used for overactive bladder, also reduces hot flashes. Useful if you have both symptoms.
• Clonidine - a blood pressure medication with modest evidence for hot flash reduction. Rarely first-line because of side effects (drowsiness, dry mouth, low blood pressure).

Vaginal and genitourinary symptoms without systemic hormones

For vaginal dryness, painful sex, and urinary symptoms, several non-hormonal options exist:

• Hyaluronic acid-based vaginal moisturizers (Revaree, Replens) used regularly
• Silicone or water-based lubricants for intercourse
• Vaginal DHEA (Intrarosa) - an intravaginal steroid that converts locally to small amounts of estrogen and testosterone. Technically a hormone but acts locally with minimal systemic absorption.
• Ospemifene (Osphena) - a selective estrogen receptor modulator (SERM) taken orally, specifically for painful sex from vaginal atrophy. Not estrogen, but acts on estrogen receptors in vaginal tissue.
• Vaginal laser therapy - evidence is mixed and varies by device; ask your provider about the latest research.

Low-dose vaginal estrogen, by the way, is often considered separately from systemic HRT because it produces minimal systemic hormone levels. Many breast cancer survivors can use vaginal estrogen with their oncologist's support.

Lifestyle interventions with real evidence

Lifestyle changes don't replace medication for most women with significant symptoms, but they have real effects:

• Cognitive behavioral therapy (CBT) for menopause - strong evidence for reducing hot flash bother (how much they interfere with life) even if not always flash frequency. Also helps with sleep and mood.
• Paced respiration and mindfulness-based stress reduction - modest evidence for hot flashes and significant evidence for anxiety and sleep.
• Weight loss (if BMI elevated) - modest but real effect on hot flash frequency.
• Reducing alcohol - alcohol is a well-documented hot flash trigger.
• Exercise - mixed evidence for hot flashes specifically, but clear benefits for mood, sleep, bone health, and cardiovascular risk.
• Room temperature and clothing adjustments - simple but genuinely helpful for flash management.

Herbs and supplements: what has evidence and what doesn't

A lot of money gets spent on supplements that don't do much. A more honest rundown:

• Black cohosh - mixed evidence; may help some women modestly
• Soy isoflavones and S-equol - modest evidence; benefit varies by individual metabolism
• Evening primrose oil - largely unsupported by evidence for menopause
• Maca, wild yam, dong quai - popular but limited high-quality evidence
• Vitamin D, magnesium, omega-3 - important for overall health but not hot flash treatments per se

Supplements can still be worth trying if you prefer that route and your provider is aware. But manage expectations, and don't spend hundreds of dollars on a supplement stack without evaluating whether it's actually doing anything.

The bottom line

Non-hormonal menopause care has come a long way. Between Veozah, SSRIs and SNRIs, gabapentin, non-hormonal vaginal options, and evidence-based lifestyle approaches, most women can build a plan that meaningfully reduces symptoms. The newer NK3 antagonists are a genuine advance that expands the toolkit for women who can't use hormones.

The key is working with a provider who knows these options and takes your symptoms seriously. Non-hormonal does not mean "do nothing." It means using the right tools for your specific situation.

This article is for educational purposes only and is not medical advice. Treatment decisions should be made with a qualified healthcare provider who can evaluate your individual health history, risk factors, and symptoms. The information here is based on current clinical guidelines and published research, but medicine evolves - always consult your provider for the most current recommendations.